Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Smith

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Contactless, photoinitiated snap-through in azobenzene-functionalized polymersM Ravi Shankar, Matthew L Smith, Vincent P Tondiglia, et al.
Genes, Chromosomes & Cancer|March 28, 2003
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2Jennifer Snaddon, Matthew L Smith, Michael Neat, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|August 1, 2023
Healthcare Utilization and Advance Care Planning among Older Adults Across Cognitive LevelsZahra Rahemi, Ayse Malatyali, Juanita-Dawne R Bacsu, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
British Journal of Haematology|July 31, 2014
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-upAma Z S Rohatiner, Matthew L Smith, Orietta Spinelli, et al.
Blood Advances|September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Contactless, photoinitiated snap-through in azobenzene-functionalized polymersM Ravi Shankar, Matthew L Smith, Vincent P Tondiglia, et al.
Genes, Chromosomes & Cancer|March 28, 2003
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2Jennifer Snaddon, Matthew L Smith, Michael Neat, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|August 1, 2023
Healthcare Utilization and Advance Care Planning among Older Adults Across Cognitive LevelsZahra Rahemi, Ayse Malatyali, Juanita-Dawne R Bacsu, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
British Journal of Haematology|July 31, 2014
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-upAma Z S Rohatiner, Matthew L Smith, Orietta Spinelli, et al.
Blood Advances|September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Pageof 4